Vimal H. Prajapati
University of Calgary(CA)
Publications by Year
Research Areas
Dermatology and Skin Diseases, Psoriasis: Treatment and Pathogenesis, Autoimmune Bullous Skin Diseases, Asthma and respiratory diseases, Allergic Rhinitis and Sensitization
Most-Cited Works
- → Efficacy and Safety of Upadacitinib vs Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis(2021)459 cited
- → The burden of alopecia areata: A scoping review focusing on quality of life, mental health and work productivity(2023)103 cited
- → Expert consensus on the systemic treatment of atopic dermatitis in special populations(2023)80 cited
- → Distinct Cutaneous Manifestations and Cold-Induced Leukocyte Activation Associated WithPLCG2Mutations(2015)66 cited
- → Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: Results from the Phase 3 randomized, controlled trial (THRIVE-AA1)(2024)66 cited
- → Efficacy and Safety of Upadacitinib Treatment in Adolescents With Moderate-to-Severe Atopic Dermatitis(2023)59 cited
- → Characterization of acne associated with upadacitinib treatment in patients with moderate-to-severe atopic dermatitis: A post hoc integrated analysis of 3 phase 3 randomized, double-blind, placebo-controlled trials(2022)57 cited
- → Roflumilast Cream, 0.15%, for Atopic Dermatitis in Adults and Children(2024)48 cited
- → Efficacy and safety of switching from dupilumab to upadacitinib versus continuous upadacitinib in moderate-to-severe atopic dermatitis: Results from an open-label extension of the phase 3, randomized, controlled trial (Heads Up)(2023)47 cited
- → Management of pediatric plaque psoriasis using biologics(2019)43 cited